CNBX PharmaceuticalsCNBX
13F holders, Q3 2024 (September 30)1holders −2
0new positions
1sold out
$0.00avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding CNBX Pharmaceuticals Inc. (CNBX) in their 13F filings, down 2 from Q2 2024. 0 opened new positions and 1 sold out. The largest holder was Archer Investment Corp ($0).
- Company
- CNBX Pharmaceuticals Inc.
- CUSIP
- 13764M209
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 15 shares sold, net −15 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Archer Investment Corp | 0.00% | No change | 9 | $0 |
"% of holder's portfolio" is CNBX's weight in each manager's 13F, not the share of CNBX Pharmaceuticals Inc. the manager owns.